

| Catalog No. | HC495014 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Description |
Anti-Human CYP24A1 Polyclonal Antibody (HC495014) is a rabbit polyclonal antibody in WB, IHC, ELISA.
Highlights
|
||||||||
| Species reactivity | Human | ||||||||
| Applications | WB, IHC, ELISA | ||||||||
| Host species | Rabbit | ||||||||
| Clonality | Polyclonal | ||||||||
| Isotype | IgG | ||||||||
| Immunogen | E. coli - derived recombinant Human CYP24A1 (Lys81-Arg514). | ||||||||
| Endotoxin level | Please contact with the lab for this information. | ||||||||
| Purity | >90% as determined by SDS-PAGE. | ||||||||
| Purification | Purified by antigen affinity column. | ||||||||
| Accession | Q07973 | ||||||||
| Form | Liquid | ||||||||
| Storage buffer | 0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300. Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA. |
||||||||
| Product Usage Information |
| ||||||||
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. | ||||||||
| Alternate Names | 125-dihydroxyvitamin D(3) 24-hydroxylase mitochondrial, 24-OHase, Vitamin D(3) 24-hydroxylase, EC:1.14.15.16, Cytochrome P450 24A1, Cytochrome P450-CC24, CYP24A1 | ||||||||
| Background | 1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial (CYP24A1) is a ~58 kDa protein. A cytochrome P450 monooxygenase with a key role in vitamin D catabolism and calcium homeostasis. Via C24- and C23-oxidation pathways, catalyzes the inactivation of both the vitamin D precursor calcidiol (25-hydroxyvitamin D(3)) and the active hormone calcitriol (1-alpha,25-dihydroxyvitamin D(3)). With initial hydroxylation at C-24 (via C24-oxidation pathway), performs a sequential 6-step oxidation of calcitriol leading to the formation of the biliary metabolite calcitroic acid. With initial hydroxylation at C-23 (via C23-oxidation pathway), catalyzes sequential oxidation of calcidiol leading to the formation of 25(OH)D3-26,23-lactone as end product. Preferentially hydroxylates at C-25 other vitamin D active metabolites, such as CYP11A1-derived secosteroids 20S-hydroxycholecalciferol and 20S,23-dihydroxycholecalciferol. 1. Sakaki, T. et al. (2000) European journal of biochemistry 267, 6158-65. PMID: 11012668 2. Sakaki, T. et al. (2005) Frontiers in bioscience : a journal and virtual library 10, 119-34. PMID: 15574355 3. Hamamoto, H. et al. (2006) Molecular pharmacology 70, 120-8. PMID: 16617161 4. Tieu, EW. et al. (2014) The FEBS journal 281, 3280-96. PMID: 24893882 5. Roizen, JD. et al. (2018) The Journal of clinical investigation 128, 1913-1918. PMID: 29461981 6. Beckman, MJ. et al. (1996) Biochemistry 35, 8465-72. PMID: 8679605 | ||||||||
| Note | For research use only. |
Contact us for custom quotes, bulk requests and any other issues.
Mail: [email protected]
+86-27-65523339
Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China
中文
English
한국어
日本語
Español
Français
Русский